In last trading session, CorMedix Inc (NASDAQ:CRMD) saw 1.49 million shares changing hands with its beta currently measuring 1.88. Company’s recent per share price level of $5.28 trading at $0.53 or 11.16% at ring of the bell on the day assigns it a market valuation of $290.29M. That closing price of CRMD’s stock is at a discount of -15.34% from its 52-week high price of $6.09 and is indicating a premium of 51.33% from its 52-week low price of $2.57. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.45 million shares which gives us an average trading volume of 440.22K if we extend that period to 3-months.
CorMedix Inc (NASDAQ:CRMD) trade information
Upright in the green during last session for gaining 11.16%, in the last five days CRMD remained trading in the green while hitting it’s week-highest on Wednesday, 04/10/24 when the stock touched $5.28 price level, adding 1.12% to its value on the day. CorMedix Inc’s shares saw a change of 40.43% in year-to-date performance and have moved 27.85% in past 5-day. CorMedix Inc (NASDAQ:CRMD) showed a performance of 50.00% in past 30-days. Number of shares sold short was 7.77 million shares which calculate 16.02 days to cover the short interests.
CorMedix Inc (CRMD) estimates and forecasts
Statistics highlight that CorMedix Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 50.00% of value to its shares in past 6 months, showing an annual growth rate of 8.79% while that of industry is 13.70. Apart from that, the company came raising its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to decrease by -16.70% in the current quarter and calculating -4.00% decrease in the next quarter.
And 4 analysts are in estimates of company making revenue of $1.67 million in the next quarter that will end on Jun 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 9.58% during past 5 years.
CRMD Dividends
CorMedix Inc is more likely to be releasing its next quarterly report in May and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
CorMedix Inc (NASDAQ:CRMD)’s Major holders
Insiders are in possession of 1.03% of company’s total shares while institution are holding 34.20 percent of that, with stock having share float percentage of 34.55%. Investors also watch the number of corporate investors in a company very closely, which is 34.20% institutions for CorMedix Inc that are currently holding shares of the company. Nomura Holdings Inc. is the top institutional holder at CRMD for having 2.95 million shares of worth $11.7 million. And as of Jun 29, 2023, it was holding 5.39% of the company’s outstanding shares.
The second largest institutional holder is Blackrock Inc., which was holding about 2.72 million shares on Jun 29, 2023. The number of shares represents firm’s hold over 4.97% of outstanding shares, having a total worth of $10.8 million.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Jun 29, 2023, the former fund manager was holding 1.65 million shares of worth $6.54 million or 3.01% of the total outstanding shares. The later fund manager was in possession of 1.01 million shares on Aug 30, 2023, making its stake of worth around $4.11 million in the company or a holder of 1.84% of company’s stock.
